Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Georges Deschênes

机构:Inserm, University of Zurich, Assistance Publique – Hôpitaux de Paris, Collaborative Group (United States), Hôpital Robert-Debré, Institut des Maladies Génétiques Imagine · ORCID:0000-0002-5158-2915

发表论文 386 篇 · 总被引 14180 次 · h-index 66

代表论文

  • Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1 (2021 · New England Journal of Medicine · 被引 512)
  • Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1 (2021 · Clinical Journal of the American Society of Nephrology · 被引 81)
  • Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children (2021 · Genetics in Medicine · 被引 74)
  • An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis (2021 · Kidney International · 被引 72)
  • Obinutuzumab in Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome in Children (2023 · Clinical Journal of the American Society of Nephrology · 被引 64)
  • The genetic landscape and clinical spectrum of nephronophthisis and related ciliopathies (2023 · Kidney International · 被引 53)